Enlicitide: The First Oral PCSK9i for Lowering Low-Density Lipoprotein Cholesterol.

求助中 10 由 jnjasonlee 发布于 2026/11/15 7:54:29

DOI:10.1177/10600280261494015
作者：Rachel C Lucas,?Mia E Lussier,?Azadeh Nasuhidehnavi,?Taylor M Clark
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1177/10600280261494015

Sage

Abstract：Objective: This article describes pharmacology, pharmacokinetics, safety, and efficacy data of enlicitide, the first Food and Drug Administration (FDA)-approved oral proprotein convertase su

应助信息

等您来应助

上传文件

43分钟前

Book学术机器人

2026/11/15 7:54:29 未找到该文献，机器人已退出，请等待人工下载

2026/11/15 7:54:29 Book学术AI机器人收到请求，开始寻找文献

2026/11/15 7:54:29 已向机器人发送请求

43分钟前

jnjasonlee 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Do AI models produce more original ideas than researchers?